- $1.32bn
- $890.60m
- $728.94m
- 72
- 25
- 69
- 55
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 276 | 430 | 516 | 629 | 729 |
Cost of Revenue | |||||
Gross Profit | 133 | 221 | 280 | 354 | 419 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 344 | 503 | 594 | 777 | 849 |
Operating Profit | -68 | -73.4 | -77.9 | -148 | -120 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -68.3 | -74.5 | -78.8 | -152 | -104 |
Provision for Income Taxes | |||||
Net Income After Taxes | -69.7 | -77.6 | -80 | -154 | -107 |
Net Income Before Extraordinary Items | |||||
Net Income | -69.7 | -77.6 | -80 | -154 | -107 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -69.7 | -77.6 | -80 | -154 | -107 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.507 | -0.565 | -0.574 | -1.1 | -0.678 |
Dividends per Share |